ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Tatva Chintan Pharma Chem Limited is communicating the process for TDS on the final dividend for FY 2025-26 to its shareholders. Shareholders are required to submit necessary tax declarations by 10 September 2026.
Tatva Chintan Pharma Chem Limited submitted its Annual Secretarial Compliance Report for FY26. The auditor confirmed total compliance with SEBI listing regulations and guidelines.
Tatva Chintan Pharma Chem Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The certificate from MUFG Intime India confirms that security certificates received for dematerialisation were processed and cancelled within prescribed timelines.